Recent studies have demonstrated that up to 1.6% of patients at very high risk for cardiovascular disease are affected by familial hypercholesterolemia (FH), highlighting a direct association between LDLR and LDL cholesterol in the pathogenesis of cardiovascular disease (Dyrbuś et al., 2021). This evidence concerns the gene LDLR and familial hyperaldosteronism.